ASSET PURCHASE AGREEMENT by and betweenAsset Purchase Agreement • October 2nd, 2023 • Vascular Biogenics Ltd. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of October 1, 2023 (the “Effective Date”), by and between Vascular Biogenics Ltd. an Israeli company (“Seller”), with its registered offices at 8 Hasatat Street, Modi’in, Israel and Immunewalk Therapeutics Inc., a Delaware company (“Buyer”), with its registered offices at 1 Blue Hill Plaza, Suite 1509, Pearl River, NY 10965. The Seller and the Buyer may be individually referred to as a “Party” and collectively as the “Parties”.
